Tango Therapeutics, Inc. (TNGX)
Across 19 earnings reports since Nov 09, 2021, Tango Therapeutics, Inc. (TNGX) has a clear post-earnings pattern. It moves ±8.95% on average after reporting and finishes higher 57.9% of the time. Its largest post-earnings gain was +36.28% (Mar 05, 2026) and its largest decline was -37.45% (Nov 06, 2024). The next earnings report is predicted for 2026-08-06 (approximate).
Earnings reactions
How TNGX moved on each past earnings report.
Earnings Impact
Total Earnings
19
Avg Abs. Movement
±8.95%
Positive %
57.9%
Negative %
42.1%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 13, 2026 | ☽ POST | -2.39% | open_in_new |
| Mar 05, 2026 | ☀ PRE | +36.28% | open_in_new |
| Nov 04, 2025 | ☀ PRE | +0% | open_in_new |
| Aug 05, 2025 | ☀ PRE | +4.86% | open_in_new |
Earnings Count
19
Total earnings in dataset
Avg Abs. Movement
±8.95%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260702 | open_in_new SEC.gov |
| 3 | 20260623 | open_in_new SEC.gov |
| 4 | 20260623 | open_in_new SEC.gov |
| 8-K | 20260623 | open_in_new SEC.gov |
| 144 | 20260617 | open_in_new SEC.gov |
| 144 | 20260611 | open_in_new SEC.gov |
| 144 | 20260610 | open_in_new SEC.gov |
| 424B5 | 20260610 | open_in_new SEC.gov |
| 8-K | 20260610 | open_in_new SEC.gov |
| FWP | 20260610 | open_in_new SEC.gov |
Frequently asked about TNGX earnings
When does Tango Therapeutics, Inc. report earnings next? expand_more
Tango Therapeutics, Inc. (TNGX)'s next earnings date is approximate for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does TNGX stock move after earnings? expand_more
Over 19 reports, TNGX has moved an average of ±8.95% the session after earnings, closing higher 57.9% of the time.
What was TNGX's biggest post-earnings move? expand_more
TNGX's largest post-earnings gain on record was +36.28% on Mar 05, 2026, and its largest decline was -37.45% on Nov 06, 2024.
Where can I find Tango Therapeutics, Inc.'s SEC filings? expand_more
All of Tango Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- Allegiant Travel CO (ALGT) earnings 2026-08-03
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arbutus Biopharma Corp (ABUS) earnings 2026-08-03
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04